Knight Therapeutics (TSE:GUD) Trading Up 0.9% – Here’s Why

Posted by Stacy Sanders on Jul 29th, 2026

Knight Therapeutics Inc. (TSE:GUD – Get Free Report)’s share price shot up 0.9% during trading on Monday . The stock traded as high as C$9.87 and last traded at C$9.82. Approximately 52,009 shares were traded during mid-day trading, a decline of 47% from the average daily volume of 97,584 shares. The stock had previously closed at C$9.73.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group set a C$9.50 price objective on Knight Therapeutics and gave the company a “buy” rating in a report on Friday, May 8th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, Knight Therapeutics currently has an average rating of “Buy” and a consensus target price of C$9.50.

View Our Latest Stock Report on Knight Therapeutics

Knight Therapeutics Stock Performance

The firm has a market capitalization of C$969.03 million, a PE ratio of 164.50, a P/E/G ratio of -1,013.50 and a beta of -0.21. The company has a debt-to-equity ratio of 8.86, a current ratio of 2.32 and a quick ratio of 1.79. The company’s fifty day simple moving average is C$9.27 and its 200 day simple moving average is C$7.66.

Knight Therapeutics (TSE:GUD – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported C$0.13 earnings per share for the quarter. Knight Therapeutics had a net margin of 1.10% and a return on equity of 0.73%. The firm had revenue of C$147.59 million during the quarter. As a group, equities research analysts expect that Knight Therapeutics Inc. will post 0.1009486 EPS for the current fiscal year.

Knight Therapeutics Company Profile

(Get Free Report)

Knight Therapeutics Inc, headquartered in Montreal, Canada, is a pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc’s shares trade on the TSX under the symbol GUD. For more information about Knight Therapeutics Inc, please visit the company’s web site at www.knighttx.com or www.sedarplus.ca.